Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences, Corteva Agriscience Collaborate on High-Throughput Sequencing

NEW YORK – Pacific Biosciences said on Monday that it is collaborating with Corteva Agriscience to develop custom workflows for plant, pest, and microbial sequencing.

Under the terms of the project, the partners will establish high-throughput workflows for DNA extraction and library preparation to enable sequencing of thousands of samples.

"This collaboration will allow us to help Corteva Agriscience characterize complex plant and microbial genomes more efficiently," PacBio President and CEO Christian Henry said in a statement.

"We see great potential in digital technologies, new seed product development tools like CRISPR-Cas gene editing, and the next generation of crop protection solutions," Greg May, Genomics Technologies lead at Corteva Agriscience, said in a statement. "Genome sequencing technology, especially when it has both long read lengths and high accuracy, is a key tool to unlocking the potential in these development areas. Using this technology at scale can help speed up the research and product development process."

Indianapolis-based Corteva is a publicly traded agricultural chemical and seed company that was spun off by DowDuPont in 2019.

The companies hope to finish their first phase of development, on sample prep, in the third quarter.

In Monday morning trading on the Nasdaq, shares of PacBio were up 3 percent at $9.76.

 

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.